Search Results - "Malgie, Jishnu"

Decreased mortality and increased side effects in COVID-19 patients treated with IL-6 receptor antagonists: systematic review and meta-analysis by Malgie, Jishnu, Schoones, Jan W., Zeegers, Maurice P., Pijls, Bart G.

“…There is controversy whether IL-6 (receptor) antagonists are beneficial in treating COVID-19 patients. We therefore update our systematic review to answer the…”
Get full text

Guideline-directed medical therapy for HFrEF: sequencing strategies and barriers for life-saving drug therapy by Malgie, Jishnu, Clephas, Pascal R. D., Brunner-La Rocca, Hans-Peter, de Boer, Rudolf A., Brugts, Jasper J.

“…Multiple landmark trials have helped to advance the treatment of heart failure with reduced ejection fraction (HFrEF) significantly over the past decade. These…”
Get full text

Haemodynamic monitoring as an opportunity for tailoring diuretics and guideline‐directed medical therapy in heart failure by Malgie, Jishnu, Brugts, Jasper J., de Boer, Rudolf A.

“…A meta-analysis of the three CardioMems trials—CHAMPION, GUIDE-HF, and MONITOR-HF—reported the use of CardioMEMS to result in a significant reduction in HF…”
Get full text

Decreased Mortality in Coronavirus Disease 2019 Patients Treated With Tocilizumab: A Rapid Systematic Review and Meta-analysis of Observational Studies by Malgie, Jishnu, Schoones, Jan W, Pijls, Bart G

“…We systematically reviewed the literature to answer the following research questions: (1) Does interleukin 6 (IL-6) (receptor) antagonist therapy reduce…”
Get full text

Decreased mortality in COVID-19 patients treated with Tocilizumab: a rapid systematic review and meta-analysis of observational studies by Malgie, Jishnu, Schoones, Jan W, Pijls, Bart G

Get full text

Reply to Richier et al by Malgie, Jishnu, Schoones, Jan W, Pijls, Bart G

Get full text

Reply to Huang et al by Malgie, Jishnu, Schoones, Jan W, Pijls, Bart G

Get full text

Reply to Tleyjeh by Malgie, Jishnu, Schoones, Jan W, Pijls, Bart G

Get full text

The different risk of new‐onset, chronic, worsening, and advanced heart failure: A systematic review and meta‐regression analysis by Shakoor, Abdul, Abou Kamar, Sabrina, Malgie, Jishnu, Kardys, Isabella, Schaap, Jeroen, Boer, Rudolf A., Mieghem, Nicolas M., Boon, Robert M.A., Brugts, Jasper J.

“…Aims Heart failure (HF) is a chronic and progressive syndrome associated with a poor prognosis. While it may seem intuitive that the risk of adverse outcomes…”
Get full text

Reply to Tleyjeh by Malgie, Jishnu, Schoones, Jan W, Pijls, Bart G

Get full text

Pulmonary artery pressure monitoring in chronic heart failure: effects across clinically relevant subgroups in the MONITOR-HF trial by Clephas, Pascal R D, Zwartkruis, Victor W, Malgie, Jishnu, van Gent, Marco W F, Brunner-La Rocca, Hans-Peter, Szymanski, Mariusz K, van Halm, Vokko P, Handoko, M Louis, Kok, Wouter E M, Asselbergs, Folkert W, van Kimmenade, Roland R J, Manintveld, Olivier C, van Mieghem, Nicolas M D A, Beeres, Saskia L M A, Post, Marco C, Borleffs, C Jan Willem, Tukkie, Raymond, Mosterd, Arend, Linssen, Gerard C M, Spee, Ruud F, Emans, Mireille E, Smilde, Tom D J, van Ramshorst, Jan, Kirchhof, Charles J H J, Feenema-Aardema, Margriet W, da Fonseca, Carlos A, van den Heuvel, Mieke, Hazeleger, Ronald, van Eck, Martijn, van Heerebeek, Loek, Boersma, Eric, Rienstra, Michiel, de Boer, Rudolf A, Brugts, Jasper J

“…Abstract Background and Aims In patients with chronic heart failure (HF), the MONITOR-HF trial demonstrated the efficacy of pulmonary artery (PA)-guided HF…”
Get full text

Contemporary g uideline‐directed medical therapy in de novo, chronic, and worsening heart failure patients: First data from the TITRATE‐HF study by Malgie, Jishnu, Wilde, Mariëlle I., Clephas, Pascal R.D., Emans, Mireille E., Koudstaal, Stefan, Schaap, Jeroen, Mosterd, Arend, van Ramshorst, Jan, Wardeh, Alexander J., van Wijk, Sandra, van den Heuvel, Mieke, Wierda, Eric, Borleffs, C. Jan Willem, Saraber, Colette, Beeres, Saskia L.M.A., van Kimmenade, Roland, Jansen Klomp, Wouter, Denham, Robert, da Fonseca, Carlos A., Klip, IJsbrand T., Manintveld, Olivier C., van der Boon, Robert M.A., van Ofwegen, Clara E.E., Yilmaz, Ayten, Pisters, Ron, Linssen, Gerard C.M., Faber, Nikola, van Heerebeek, Loek, van de Swaluw, Julio E.C., Bouhuijzen, Lex J., Post, Marco C., Kuijper, Aaf F.M., Wu, Ka wai, van Beek, Eugène A., Hesselink, Tim, Kleijn, Lennaert, Kurvers, Maurice J.M., Tio, René A., Langerveld, Jorina, van Dalen, Bas M., van Eck, J.W. Martijn, Handoko, M. Louis, Hermans, Walter R.M., Koornstra‐Wortel, Hetty J.J., Szymanski, Mariusz K., Rooker, Dennis, Tandjung, Kenneth, Eijsbouts, Sabine C.M., Asselbergs, Folkert W., van der Meer, Peter, Brunner‐La Rocca, Hans‐Peter, de Boer, Rudolf A., Brugts, Jasper J.

“…Abstract Aims Despite clear guideline recommendations for initiating four drug classes in all patients with heart failure (HF) with reduced ejection fraction…”
Get full text

Guideline implementation, drug sequencing, and quality of care in heart failure: design and rationale of TITRATE‐HF by Clephas, Pascal R. D., Malgie, Jishnu, Schaap, Jeroen, Koudstaal, Stefan, Emans, Mireille, Linssen, Gerard C. M., Boer, Grytsje A., Heerebeek, Loek, Borleffs, C. Jan Willem, Manintveld, Olivier C., Empel, Vanessa, Wijk, Sandra, Heuvel, Mieke, Fonseca, Carlos, Damman, Kevin, Ramshorst, Jan, Kimmenade, Roland, Ven, Arjen R. T., Tio, René A., Veghel, Dennis, Asselbergs, Folkert W., Boer, Rudolf A., Meer, Peter, Greene, Stephen J., Brunner‐La Rocca, Hans‐Peter, Brugts, Jasper J.

“…Aims Current heart failure (HF) guidelines recommend to prescribe four drug classes in patients with HF with reduced ejection fraction (HFrEF). A clear…”
Get full text